Alterations in HER2, a receptor tyrosine kinase involved in regulating cell growth and differentiation, are present in 1–4% of NSCLC cases [91], and the ERBB2 gene, located on chromosome 17, can be impacted by various genetic abnormalities [91,92]. Here, ERBB2 is linked to non-small cell lung carcinoma.